Active trachoma and ocular Chlamydia trachomatis infection in two Gambian regions: on course for elimination by 2020?

scientific article

Active trachoma and ocular Chlamydia trachomatis infection in two Gambian regions: on course for elimination by 2020? is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1371/JOURNAL.PNTD.0000573
P932PMC publication ID2791206
P698PubMed publication ID20027217
P5875ResearchGate publication ID40757730

P50authorRobin L BaileyQ84098967
Tansy EdwardsQ91794833
Sandra Milena Rojas MolinaQ91913244
Ansumana SillahQ114445828
Esther A N AryeeQ114445841
Isatou SarrQ116792559
David MabeyQ37834883
Martin J HollandQ43415769
Chrissy H RobertsQ56426648
Emma M Harding-EschQ57059045
P2093author name stringPaul Snell
P2860cites workGlobal data on visual impairment in the year 2002Q24650312
A simple system for the assessment of trachoma and its complicationsQ24652915
The Measurement of Observer Agreement for Categorical DataQ26778373
Multiple Chlamydiaceae species in trachoma: implications for disease pathogenesis and controlQ28471929
Conjunctival FOXP3 expression in trachoma: do regulatory T cells have a role in human ocular Chlamydia trachomatis infection?Q33252477
Virus infections of the eye.Q33682990
Multiplex amplification of mitochondrial DNA for human and species identification in forensic evaluationQ74656356
Use of flocked swabs and a universal transport medium to enhance molecular detection of Chlamydia trachomatis and Neisseria gonorrhoeaeQ34431893
Trachoma in The GambiaQ35306362
Evaluation of a national eye care programme: re-survey after 10 yearsQ35316466
Detection of Chlamydia trachomatis in genital swabs: comparison of commercial and in house amplification methods with cultureQ35562221
Diagnosis and assessment of trachoma.Q35920659
Clinical examination and laboratory tests for estimation of trachoma prevalence in a remote setting: what are they really telling us?Q36108096
Reliability of clinical diagnosis in identifying infectious trachoma in a low-prevalence area of NepalQ36918265
Identification of a new group of Chlamydia psittaci strains called TWAR.Q37213605
Risk factors for active trachoma in The Gambia.Q37331405
Evaluation of three years of the SAFE strategy (Surgery, Antibiotics, Facial cleanliness and Environmental improvement) for trachoma control in five districts of Ethiopia hyperendemic for trachomaQ37855615
The impact of community level treatment and preventative interventions on trachoma prevalence in rural EthiopiaQ37857807
Quality assessment of conjunctival specimens for detection of Chlamydia trachomatis by PCR in children with active trachomaQ37860012
Field evaluation of a rapid point-of-care assay for targeting antibiotic treatment for trachoma control: a comparative study.Q37862275
Conjunctival chlamydial 16S ribosomal RNA expression in trachoma: is chlamydial metabolic activity required for disease to develop?Q37863110
Re-emergence of Chlamydia trachomatis infection after mass antibiotic treatment of a trachoma-endemic Gambian community: a longitudinal studyQ37865086
Mass treatment with single-dose azithromycin for trachoma.Q37866138
How reliable is the clinical exam in detecting ocular chlamydial infection?Q37866456
Which members of a community need antibiotics to control trachoma? Conjunctival Chlamydia trachomatis infection load in Gambian villagesQ37868556
Strategies for control of trachoma: observational study with quantitative PCR.Q37868938
Does the Diagnosis of Trachoma Adequately Identify Ocular Chlamydial Infection in Trachoma‐Endemic Areas?Q37869544
Does clinical diagnosis indicate ocular chlamydial infection in areas with a low prevalence of trachoma?Q37871394
Pooling of Chlamydia laboratory tests to determine the prevalence of ocular Chlamydia trachomatis infectionQ37873795
Azithromycin in control of trachomaQ37877870
Chronic follicular conjunctivitis associated with Chlamydia psittaci or Chlamydia pneumoniaeQ37880791
Reduction of trachoma in a sub-Saharan village in absence of a disease control programmeQ37882805
Polymerase chain reaction for the detection of ocular chlamydial infection in trachoma-endemic communitiesQ37888362
Importance of reinfection in the pathogenesis of trachomaQ37903781
Chlamydial infection. Results of micro-immunofluorescence tests for the detection of type-specific antibody in certain chlamydial infectionsQ37913484
A simplified general method for cluster-sample surveys of health in developing countriesQ38904070
Two doses of azithromycin to eliminate trachoma in a Tanzanian community.Q43415711
TrachomaQ56040927
Trachoma in Punjabi Indians in British Columbia: a prevalence study with comparisons to IndiaQ72866606
P275copyright licenseCreative Commons Attribution 2.5 GenericQ18810333
P433issue12
P407language of work or nameEnglishQ1860
P921main subjectThe GambiaQ1005
Chlamydia trachomatisQ131065
trachomaQ193216
P5008on focus list of Wikimedia projectScienceSourceQ55439927
P304page(s)e573
P577publication date2009-12-22
P1433published inPLoS Neglected Tropical DiseasesQ3359737
P1476titleActive trachoma and ocular Chlamydia trachomatis infection in two Gambian regions: on course for elimination by 2020?
P478volume3

Reverse relations

cites work (P2860)
Q28534860Association between ocular bacterial carriage and follicular trachoma following mass azithromycin distribution in The Gambia
Q36508898Can corneal pannus with trachomatous inflammation--follicular be used in combination as an improved specific clinical sign for current ocular Chlamydia trachomatis infection?
Q34291171Characterization of Pgp3, aChlamydia trachomatisPlasmid-Encoded Immunodominant Antigen
Q31134167Comparing the performance of cluster random sampling and integrated threshold mapping for targeting trachoma control, using computer simulation
Q90267031Conjunctival Microbiome-Host Responses Are Associated With Impaired Epithelial Cell Health in Both Early and Late Stages of Trachoma
Q28546645Costs of testing for ocular Chlamydia trachomatis infection compared to mass drug administration for trachoma in the Gambia: application of results from the PRET study
Q28554221Cross-Sectional Surveys of the Prevalence of Follicular Trachoma and Trichiasis in The Gambia: Has Elimination Been Reached?
Q49940948Current Research of Chlamydial Infection Diseases in China
Q36252526Defining Seropositivity Thresholds for Use in Trachoma Elimination Studies.
Q33806236Design and baseline data of a randomized trial to evaluate coverage and frequency of mass treatment with azithromycin: the Partnership for Rapid Elimination of Trachoma (PRET) in Tanzania and The Gambia
Q36971207Development and evaluation of a next-generation digital PCR diagnostic assay for ocular Chlamydia trachomatis infections
Q33988876Diagnostic accuracy of a prototype point-of-care test for ocular Chlamydia trachomatis under field conditions in The Gambia and Senegal
Q33605498Follicular trachoma and trichiasis prevalence in an urban community in The Gambia, West Africa: is there a need to include urban areas in national trachoma surveillance?
Q40054962HSV-2 enhances ZIKV infection of the placenta and induces apoptosis in first-trimester trophoblast cells
Q33605747Haptoglobin and sickle cell polymorphisms and risk of active trachoma in Gambian children
Q36668534Health Beliefs and Perceptions of Trachoma in Communities on the Bijagos Archipelago of Guinea Bissau
Q90298721Identification of proteins interacting with pORF5 in the pathogenesis of C. trachomatis
Q28596379Low Prevalence of Ocular Chlamydia trachomatis Infection and Active Trachoma in the Western Division of Fiji
Q28533873Mass treatment with azithromycin for trachoma: when is one round enough? Results from the PRET Trial in the Gambia
Q28542612Non-participation during azithromycin mass treatment for trachoma in The Gambia: heterogeneity and risk factors
Q34022544Pathway-focused arrays reveal increased matrix metalloproteinase-7 (matrilysin) transcription in trachomatous trichiasis.
Q37833738Population-based prevalence survey of follicular trachoma and trachomatous trichiasis in the Casamance region of Senegal
Q35830966Prevalence and associated factors of active trachoma among childeren aged 1-9 years in rural communities of Gonji Kolella district, West Gojjam zone, North West Ethiopia
Q33721962Profound and sustained reduction in Chlamydia trachomatis in The Gambia: a five-year longitudinal study of trachoma endemic communities
Q36640577Risk of Infection with Chlamydia trachomatis from Migrants to Communities Undergoing Mass Drug Administration for Trachoma Control
Q88922669School-Based versus Community-Based Sampling for Trachoma Surveillance
Q43366299Serology reflects a decline in the prevalence of trachoma in two regions of The Gambia
Q43225051Stability of Chlamydia trachomatis on storage of dry swabs for accurate detection by nucleic acid amplification tests
Q35084474Systemic effector and regulatory immune responses to chlamydial antigens in trachomatous trichiasis
Q28552982The Relationship between Active Trachoma and Ocular Chlamydia trachomatis Infection before and after Mass Antibiotic Treatment
Q34636094The conjunctival microbiome in health and trachomatous disease: a case control study
Q37407454The epidemiological dynamics of infectious trachoma may facilitate elimination
Q34952343The geographical distribution and burden of trachoma in Africa
Q33745187Trachoma prevalence and associated risk factors in the gambia and Tanzania: baseline results of a cluster randomised controlled trial
Q34496498Trophoblast-microbiome interaction: a new paradigm on immune regulation.
Q37846762Using a nonparametric multilevel latent Markov model to evaluate diagnostics for trachoma
Q35221283What is causing active trachoma? The role of nonchlamydial bacterial pathogens in a low prevalence setting
Q28474778Where do we go from here? Prevalence of trachoma three years after stopping mass distribution of antibiotics in the regions of Kayes and Koulikoro, Mali

Search more.